Italy's New Govt to Lower E-Cigarette Tax in Budget

Dec.09.2022
Italy's New Govt to Lower E-Cigarette Tax in Budget
Italy's new Meloni government plans to reduce taxes on e-cigarette liquid, providing relief for users and suppliers.

The new Meloni government in Italy has directly included a reduction in the consumption tax on e-cigarette liquid in the budget law. In fact, starting from January 2023, the tax on e-cigarette liquid will double due to the previous Conte government passing the budget law. For the uninitiated, all liquids intended for inhalation, whether containing nicotine or not, that are suitable for use with e-cigarettes are subject to appropriate consumption taxes just like traditional cigarettes as they belong to the national monopoly.


In summary, it appears that the price of e-cigarette liquid will remain steady starting in January. This will allow hundreds of thousands of Italian e-cigarette users to continue the habit of quitting smoking at a very low monthly cost. In fact, e-cigarettes have become an effective method for quitting smoking. Thanks to the new budget law, there will be no maximum increase (although the tax imposed on each bottle of alcohol will double), and the final decision will be made by the national accounting department. However, predictions are not just positive, but seem to be on the cover of everything. In short, this is good news for all participants in the e-cigarette supply chain, from e-liquid producers to retailers and end consumers, all of whom can breathe a sigh of relief. For some time now, e-cigarette retailers and manufacturers have been expecting news like this. Having a "fixed" tax that does not increase every year can allow you to expand production, distribution, and sales networks, increase job opportunities, and provide an effective tool to fight traditional smoking for more and more people.


After being sent to Brussels, the text of the budget law will be reviewed by the parliament and may be subject to modifications. However, statements from the government and armored figures from the parliament seem to ensure the certainty that Article 28 will not be altered. The same article also stipulates a slight increase in consumer tax on traditional tobacco (which actually occurs annually) in order to make up for the reduced tax on electronic and heated tobacco, which are considered lower-risk products. Assessing the current situation, the government has seemingly sent an important signal to the world of electronic cigarettes, an industry that employs tens of thousands in Italy.


In short, this is good news for loyal customers who use DEA flavored liquids, which are fully manufactured in Trento, Italy by one of the major players in the industry. Best-selling products under the DEA brand such as DEA Calliope, DEA Venere, DEA Nemesi, DEA Cuba liquids, and all other DEA brands will maintain their current prices next year.


Even DIY electronic cigarette enthusiasts stick to the concentrated flavors and neutral base they are accustomed to using. The infamous nicotine bristle remains the best-selling item in specialty stores and will maintain its price. These bristles are typically made up of just three components (propylene glycol, vegetable glycerin, and precise levels of nicotine chosen by the consumer) and play an important role for those who prefer to make their own liquid using certified and compliant products. Concentrated flavorings, like common food flavorings used for candies and cookies, are excluded from the national monopoly consumption tax. The vital first step taken by Meloni's government is hoped to provide a lifeline for the increasing number of citizens at present.


2FIRSTS will continue to follow and report on this issue, with further updates available on our app '2FIRSTSAPP.' Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
According to VitalLaw on August 27, 2026, the U.S. Court of Appeals for the Fifth Circuit vacated an FDA marketing denial order (MDO) against NicQuid LLC, ruling that the agency’s comparative-efficacy standard for electronic nicotine delivery system (ENDS) applications had become a substantive rule requiring notice-and-comment rulemaking under the Administrative Procedure Act (APA). The court did not reject FDA’s authority to compare the public health benefits and risks of flavored vapes, but held that the agency could not establish a broadly binding standard through informal adjudications. The case was remanded to FDA for further proceedings.
Aug.28
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24
Philip Morris Romania Executive on Smoke-Free Strategy: How IQOS Spaces Are Moving Beyond Retail to Consumer Connection
Philip Morris Romania Executive on Smoke-Free Strategy: How IQOS Spaces Are Moving Beyond Retail to Consumer Connection
In an interview with Romanian marketing publication IQads, Marek Gębski, Director of Smoke-Free Products at Philip Morris Romania, said IQOS experience spaces are evolving from traditional retail locations into platforms for consumer engagement and brand connection. Through locations such as IQOS Boutique Victoriei, PMI aims to use design, culture and consumer experiences to strengthen communication with adult consumers about smoke-free products. The interview highlights how tobacco companies are expanding smoke-free strategies beyond products toward experiential marketing and consumer relationships.
Aug.11
Product | KIWI Launches Spark 2 and Spark 2 Pro in Germany, Two Hardware Tiers Share Backward-Compatible 2ml Pods
Product | KIWI Launches Spark 2 and Spark 2 Pro in Germany, Two Hardware Tiers Share Backward-Compatible 2ml Pods
KIWI has launched the Spark 2 and Spark 2 Pro refillable pod systems in Germany at official prices of €18 and €29, respectively. Spark 2 uses an 800mAh removable lithium-ion battery in a pen-style body, while Spark 2 Pro features a 1,400mAh removable battery, a box-shaped design and vibration feedback every 20 puffs. Both devices use the same 2ml Spark V2 pods in 0.8Ω and 1.2Ω versions, with AirSync airflow adjustment and a choice between Cotton Tips and conventional Drip Tips. The new pods also remain compatible with the original KIWI Spark.
News
Sep.29 by 2Firsts Perspectives
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives